Symptom Research
Neuroimmunology Laboratories
Robert Dantzer, Ph.D. | Peter Grace, Ph.D. | Yuan Pan, Ph.D. | Andrew J. Shepherd, Ph.D.
Principal Investigators
Areas of Research
- Chemotherapy-Induced Neuropathy
- Chemotherapy-Induced Cognitive Impairments
- Chronic Pain
- Fatigue
- Depression
- Neuron-glia Interactions
The Neuroimmunology Laboratories are led by four well-funded, collaborative principal investigators who share space, equipment, and ideas in a highly interactive, international, research-focused environment. The overall aim of these laboratories is to increase our understanding of the pathophysiology of cancer therapy-induced neurobehavioral toxicities, including neuropathic pain, depressed mood, cognitive dysfunction, and fatigue. This newly acquired knowledge can then be applied to the rational design of novel interventions for alleviating symptom burden in patients with cancer.
Please join us for the next Neurobiology Seminar Series lecture
Title: TBD
Speaker: Kyle M. Baumbauer, Ph.D.
Assistant Professor, Department of Anesthesiology, Pain and Perioperative Medicine
University of Kansas
February 7, 2025 ● 11:00 am - 12:00 pm CST
Zayed Building, Z2.4040 Rooms 2 and 3
Or join us on Zoom
Meeting ID: 853 8938 0073 ● Password: 155935
The Neuroimmunology Laboratories
Pain Research Symposium
ADVANCEMENTS IN TRANSLATIONAL SCIENCE FOR PAIN MANAGEMENT IN CANCER CARE: This symposium will connect you with MD Anderson clinical and basic science experts dedicated to ending pain for cancer patients and survivors. Engage in poster sessions, talks, and patient-caregiver panels to exchange insights and foster collaboration.
May 9, 2025 – Learn More and Register